Immunosuppression: evolution in practice and trends, 1994-2004. (Q36448818)

14 August 2017

title

Immunosuppression: evolution in practice and trends, 1994-2004. (English)

1 reference

14 August 2017

1 reference

4

Fung JJ

1 reference

14 August 2017

Meier-Kriesche HU

1

1 reference

14 August 2017

Li S

2

1 reference

14 August 2017

Gruessner RW

3

1 reference

14 August 2017

Bustami RT

5

1 reference

14 August 2017

Barr ML

6

1 reference

14 August 2017

Leichtman AB

7

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

American Journal of Transplantation

14 August 2017

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

5 Pt 2

1 reference

14 August 2017

page(s)

1111-1131

1 reference

Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

Single-agent immunosuppression after liver transplantation: what is possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

The use of mycophenolate mofetil in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

Immunosuppression: evolution in practice and trends, 1993-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01270.X

10.1111/J.1600-6143.2006.01270.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference